PACED-digitized Support During Adjuvant Endocrine Therapy

Launched by REGION STOCKHOLM · Oct 19, 2021

Keywords

ClinConnect Summary

The PACED trial is exploring how a digital support app can help women with hormone receptor positive breast cancer who are undergoing preventive hormone treatment. The goal is to see if using this app can lead to fewer late side effects, improve their quality of life, and help them stick to their treatment plans better.

To be eligible for this study, participants need to be female, aged between 65 and 74, and have started their hormone treatment within the last 16 weeks. They should not have any cognitive impairments, and they must have access to a mobile phone and the internet. If you join the study, you can expect to use the app as part of your treatment journey, which may provide helpful resources and support. This research is currently recruiting participants, so it’s a great opportunity for those who qualify to contribute to a study that may improve care for future patients.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Hormone receptor positive breast cancer
• • On adjuvant endocrine treatment 0-16 weeks ago
• Exclusion Criteria:
• • Cognitively impaired
• • No access to a mobile phone or internet
• • Not understanding Swedish